Mallinckrodt medical sales rise 15% in third quarter:
This article was originally published in Clinica
Executive Summary
Mallinckrodt Medical has reported third-quarter sales of $255.5 million, 15% higher than a year earlier. Mallinckrodt says that its medical division had strong sales in all areas despite continuing downward pressure from healthcare cost reduction efforts. In the first nine months of fiscal 1995 sales rose 12% to $725.7 million. Mallinckrodt's group sales were up 17% to $569.1 million in the third quarter (ended March 31st). Net income improved to $47 million compared with $42.3 million in the same 1994 period.